<i>TERT</i>promoter mutations contribute to<i>IDH</i>mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas

Ying Mao, Xiaojie Ding, Zhiyong Qin et al.|Oncotarget|2015

Cited by 36